Rhinitis, Allergic, Perennial and Seasonal Clinical Trial
Official title:
A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis
The purpose of this study is to assess any effect in children with seasonal and/or perennial allergic rhinitis by GW685698X aqueous nasal spray (versus vehicle placebo nasal spray) on growth using knemometry.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02424539 -
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
|
Phase 4 | |
| Completed |
NCT01957202 -
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
|
Phase 2 | |
| Completed |
NCT01949051 -
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
|
Phase 2 | |
| Completed |
NCT01962467 -
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
|
Phase 1 | |
| Completed |
NCT01001130 -
Regulatory AVAMYS Nasal Spray PMS
|
N/A | |
| Completed |
NCT01622283 -
Pharmacokinetic Study of Levocetirizine Oral Solution
|
Phase 1 | |
| Completed |
NCT02397915 -
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
|
Phase 4 | |
| Completed |
NCT01445262 -
Drug Use Investigation for XYZAL®
|
N/A | |
| Completed |
NCT01916226 -
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
|
Phase 4 |